First Light Asset Management, LLC Reata Pharmaceuticals Inc Transaction History

First Light Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $12.3 Million - $16.3 Million	-154,720 Reduced 9.75%	1,432,208 $146 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $14.7 Million - $44.3 Million	-475,525 Reduced 23.06%	1,586,928 $144 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $22.3 Million - $42.4 Million	1,007,468 Added 95.5%	2,062,453 $78.4 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $20.5 Million - $38.5 Million	1,054,985 New	1,054,985 $26.5 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.